Richard J Daly - Net Worth and Insider Trading
Richard J Daly Net Worth
The estimated net worth of Richard J Daly is at least $6 Million dollars as of 2024-11-10. Richard J Daly is the President and CEO of Catalyst Pharmaceuticals Inc and owns about 234,824 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $6 Million. Richard J Daly is the Director of Opiant Pharmaceuticals Inc and owns about 1,800 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $37,170. Richard J Daly is also the CEO of Seneca Biopharma Inc and owns about 194 shares of Seneca Biopharma Inc (SNCA) stock worth over $1,932. Details can be seen in Richard J Daly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard J Daly has not made any transactions after 2024-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard J Daly
Richard J Daly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard J Daly owns 5 companies in total, including Opiant Pharmaceuticals Inc (OPNT) , Catalyst Pharmaceuticals Inc (CPRX) , and Seneca Biopharma Inc (SNCA) among others .
Click here to see the complete history of Richard J Daly’s form 4 insider trades.
Insider Ownership Summary of Richard J Daly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2019-09-12 | director |
| CPRX | Catalyst Pharmaceuticals Inc | 2024-06-04 | director |
| SNCA | Seneca Biopharma Inc | 2017-11-07 | director & Chief Executive Officer |
 | | 2017-06-28 | director |
| | 2016-02-15 | director & CEO & President |
Richard J Daly Latest Holdings Summary
Richard J Daly currently owns a total of 3 stocks. Among these stocks, Richard J Daly owns 234,824 shares of Catalyst Pharmaceuticals Inc (CPRX) as of June 4, 2024, with a value of $6 Million and a weighting of 99.31%. Richard J Daly owns 1,800 shares of Opiant Pharmaceuticals Inc (OPNT) as of September 12, 2019, with a value of $37,170 and a weighting of 0.66%. Richard J Daly also owns 194 shares of Seneca Biopharma Inc (SNCA) as of May 17, 2017, with a value of $1,932 and a weighting of 0.03%.
Latest Holdings of Richard J Daly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-06-04 | 234,824 | 23.93 | 5,619,338 |
| OPNT | Opiant Pharmaceuticals Inc | 2019-09-12 | 1,800 | 20.65 | 37,170 |
| SNCA | Seneca Biopharma Inc | 2017-05-17 | 194 | 9.96 | 1,932 |
Holding Weightings of Richard J Daly
Richard J Daly Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard J Daly has made a total of 1 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 17,323 shares on June 4, 2024, which brought Richard J Daly around $276,822.
According to the SEC Form 4 filings, Richard J Daly has made a total of 0 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years. The most-recent trade in Opiant Pharmaceuticals Inc is the acquisition of 1,800 shares on September 12, 2019, which cost Richard J Daly around $25,020.
According to the SEC Form 4 filings, Richard J Daly has made a total of 0 transactions in Seneca Biopharma Inc (SNCA) over the past 5 years. The most-recent trade in Seneca Biopharma Inc is the acquisition of 63 shares on May 17, 2017, which cost Richard J Daly around $30,000.
Insider Trading History of Richard J Daly
- 1
Richard J Daly Trading Performance
GuruFocus tracks the stock performance after each of Richard J Daly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard J Daly is 2.24%. GuruFocus also compares Richard J Daly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard J Daly within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard J Daly's insider trading performs compared to the benchmark.
Performance of Richard J Daly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.69 | | | | | |
| Relative Return to S&P 500(%) | 7.63 | | | | | |
Richard J Daly Ownership Network
Ownership Network List of Richard J Daly
Ownership Network Relation of Richard J Daly
Richard J Daly Owned Company Details
What does Opiant Pharmaceuticals Inc do?
Who are the key executives at Opiant Pharmaceuticals Inc?
Richard J Daly is the director of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and director & 10 percent owner & Chief Executive Officer Roger Crystal .
Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Opiant Pharmaceuticals Inc Insider Transactions
Richard J Daly Mailing Address
Above is the net worth, insider trading, and ownership report for Richard J Daly. You might contact Richard J Daly via mailing address: 355 Alhambra Circle, Suite 1500, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
